Which companies overlap with Cristália Produtos Químicos Farmacêuticos Ltda.'s portfolio?

Top competitors by shared drug class: Peking Union Medical College Hospital, HaEmek Medical Center, Israel, Medical University of Vienna, Oregon Health and Science University, Assistance Publique - Hôpitaux de Paris.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/crist-lia-produtos-qu-micos-farmac-uticos-ltda.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Cristália Produtos Químicos Farmacêuticos Ltda. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cristália Produtos Químicos Farmacêuticos Ltda. pipeline: 2 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 0 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Fentanyl Transdermal	Fentanyl Transdermal	marketed	Opioid Agonist [EPC]	mu-receptor
Nitroprusside, Sodium	Nitroprusside, Sodium	marketed	Nitrovasodilator	Soluble guanylate cyclase (via nitric oxide)	Cardiovascular
bupivacaine S50:R50 plus 8% glucose	bupivacaine S50:R50 plus 8% glucose	phase 3	Local anesthetic	Voltage-gated sodium channels	Anesthesia
Sodium Enoxaparin clexane	Sodium Enoxaparin clexane	phase 3	Low-molecular-weight heparin (LMWH)	Coagulation factors Xa and IIa (via antithrombin III)	Cardiovascular
bupivacaine S75:R25 plus 8% glucose	bupivacaine S75:R25 plus 8% glucose	phase 3	Local anesthetic	Voltage-gated sodium channels	Anesthesiology

Therapeutic area mix

Cardiovascular · 2
Anesthesia · 1
Anesthesiology · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Peking Union Medical College Hospital · 2 shared drug classes
HaEmek Medical Center, Israel · 2 shared drug classes
Medical University of Vienna · 2 shared drug classes
Oregon Health and Science University · 2 shared drug classes
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Atlantic Health System · 1 shared drug class
Ain Shams Maternity Hospital · 1 shared drug class
Aligarh Muslim University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Cristália Produtos Químicos Farmacêuticos Ltda.:

Cite this brief

Drug Landscape (2026). Cristália Produtos Químicos Farmacêuticos Ltda. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/crist-lia-produtos-qu-micos-farmac-uticos-ltda. Accessed 2026-05-17.